Clinical Trial

Early Feasibility Study of the Velocity™ Percutaneous Arterio-Venous Fistula System for Creating Hemodialysis Vascular Access

Study acronym: VENOS-2
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The Velocity Percutaneous Arterio-Venous System is a minimally invasive method of creating hemodialysis vascular access. The study aims to understand clinical efficacy and initial clinical safety data of the device.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-11-25; most recent amendment 2025-08-12.
Status change: Recruiting → Active, Not Recruiting 2025-08-12
Status change: Not Yet Recruiting → Recruiting 2025-01-13
Trial Details
NCT Number NCT06712251
Lead Sponsor Venova Medical
Conditions Chronic Kidney Disease Requiring Hemodialysis, End Stage Renal Disease (ESRD)
Enrollment 20 participants
Start Date 2025-01-08
Primary Completion 2025-05-15 (estimated)
Study Completion 2027-01-04 (estimated)
Updated on ClinicalTrials.gov 2025-08-17